Replies to post #461454 on Anavex Life Sciences Corp (AVXL)

[Steady_T]

There is no way that approval of 2-73 is going to impact the number of drugs applying for approval which is where the FDA gets that 70%. That money is application fees that EVERY company pays unless it is for an orphan drug, at which point the fees are waved.

That argument is bogus.